Your browser is no longer supported. Please, upgrade your browser.
Settings
NLNK NewLink Genetics Corporation daily Stock Chart
NLNK [NASD]
NewLink Genetics Corporation
Index- P/E- EPS (ttm)-1.53 Insider Own0.20% Shs Outstand38.46M Perf Week-10.28%
Market Cap73.84M Forward P/E- EPS next Y-0.70 Insider Trans-15.22% Shs Float26.25M Perf Month-11.52%
Income-56.70M PEG- EPS next Q-0.33 Inst Own44.50% Short Float6.01% Perf Quarter-30.43%
Sales22.40M P/S3.30 EPS this Y21.80% Inst Trans2.99% Short Ratio3.17 Perf Half Y-63.64%
Book/sh3.28 P/B0.59 EPS next Y54.20% ROA-35.80% Target Price4.67 Perf Year-78.43%
Cash/sh3.17 P/C0.60 EPS next 5Y17.90% ROE-42.30% 52W Range1.86 - 10.41 Perf YTD-76.33%
Dividend- P/FCF- EPS past 5Y-15.40% ROI-47.60% 52W High-81.56% Beta1.48
Dividend %- Quick Ratio13.30 Sales past 5Y76.30% Gross Margin- 52W Low3.50% ATR0.16
Employees76 Current Ratio13.30 Sales Q/Q-98.20% Oper. Margin- RSI (14)38.04 Volatility6.87% 7.91%
OptionableYes Debt/Eq0.00 EPS Q/Q71.10% Profit Margin- Rel Volume0.86 Prev Close1.98
ShortableYes LT Debt/Eq0.00 EarningsNov 01 AMC Payout- Avg Volume497.46K Price1.92
Recom3.00 SMA20-7.85% SMA50-17.11% SMA200-58.31% Volume426,248 Change-3.03%
Aug-01-18Downgrade Stifel Buy → Hold $8 → $4
Apr-09-18Downgrade Robert W. Baird Outperform → Neutral
Apr-09-18Downgrade Jefferies Buy → Hold
Apr-09-18Downgrade Cantor Fitzgerald Overweight → Neutral
Apr-06-18Downgrade SunTrust Buy → Hold
Oct-13-17Initiated BofA/Merrill Buy $22
Sep-11-17Reiterated Stifel Buy $14 → $29
Sep-08-17Upgrade Robert W. Baird Neutral → Outperform $8 → $22
Sep-08-17Upgrade Jefferies Hold → Buy
Jun-08-17Downgrade Robert W. Baird Outperform → Neutral $25 → $8
Mar-30-17Upgrade SunTrust Hold → Buy
May-11-16Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
May-10-16Reiterated Stifel Buy $63 → $23
May-10-16Reiterated Mizuho Buy $52 → $20
Mar-23-16Initiated Robert W. Baird Outperform $27
Mar-01-16Reiterated Mizuho Buy $62 → $52
Jul-15-15Reiterated Mizuho Buy $50 → $62
Jul-15-15Reiterated Cantor Fitzgerald Buy $44 → $62
May-06-15Reiterated Stifel Buy $59 → $63
Nov-07-14Reiterated Stifel Buy $51 → $55
Nov-09-18 08:00AM  NewLink Genetics Presents Phase 1 Data Supporting Significantly Higher Exposure with Indoximod Prodrug, NLG802, and Biomarker Data from Two Phase 2 Trials Illustrating Indoximods Impact on the Tumor Microenvironment at SITC 2018 GlobeNewswire
Nov-06-18 09:00AM  NewLink Genetics Announces Publication of Abstracts for Presentation at the Society for Immunotherapy for Cancer (SITC) Conference GlobeNewswire
07:25AM  Analysis: Positioning to Benefit within Mercury, Lincoln Electric, Sprint, Fred's, NewLink Genetics, and El Paso Electric Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-05-18 03:54PM  Is the Options Market Predicting a Spike in NewLink Genetics (NLNK) Stock? (revised) Zacks
08:55AM  Is the Options Market Predicting a Spike in Hertz NewLink Genetics (NLNK) Stock? Zacks
Nov-02-18 06:01PM  Edited Transcript of NLNK earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents -6.61%
05:05PM  CORRECTED: NewLink Genetics Reports Third Quarter 2018 Financial Results and Announces Abstracts to Be Presented at Upcoming Medical Meetings GlobeNewswire
07:30AM  NewLink Genetics (NLNK) Reports Q3 Loss, Lags Revenue Estimates Zacks
05:07AM  NewLink: 3Q Earnings Snapshot Associated Press
Nov-01-18 04:01PM  NewLink Genetics Reports Third Quarter 2018 Financial Results and Announces Abstracts to Be Presented at Upcoming Medical Meetings GlobeNewswire +20.11%
10:00AM  NewLink Genetics Announces Oral Presentation at the 2018 American Society of Hematology (ASH) Annual Meeting GlobeNewswire
Oct-30-18 09:00AM  NewLink Genetics to Participate in the Stifel 2018 Healthcare Conference GlobeNewswire
Oct-25-18 10:34AM  NewLink Genetics (NLNK) Q3 Earnings Preview: What to Expect Zacks
Oct-18-18 04:01PM  NewLink Genetics to Host Its Third Quarter 2018 Financial Results Conference Call on November 1, 2018 GlobeNewswire
Oct-16-18 09:20AM  Analysis: Positioning to Benefit within ChemoCentryx, Armstrong Flooring, Kornit Digital, NewLink Genetics, Silvercorp Metals, and Halcon Resources Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Oct-01-18 05:15PM  NewLink Genetics Announces Indoximod Biomarker Data and Prodrug NLG802 Pharmacokinetic Data to be Presented at SITC 2018 GlobeNewswire
Sep-18-18 11:25AM  Whats Ahead For NewLink Genetics Corporation (NASDAQ:NLNK)? Simply Wall St.
09:00AM  NewLink Genetics to Participate in the Cantor Global Healthcare Conference GlobeNewswire
Aug-21-18 09:00AM  NewLink Genetics to Participate in the Baird Global Healthcare Conference GlobeNewswire
Aug-20-18 08:10AM  Report: Exploring Fundamental Drivers Behind Codexis, Kornit Digital, NewLink Genetics, NCS Multistage, Mountain Province Diamonds, and CSS Industries New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-06-18 09:29PM  Edited Transcript of NLNK earnings conference call or presentation 31-Jul-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-01-18 03:31PM  Stifel Cuts NewLink Valuation Estimate In Half On Regulatory, Development Risks Benzinga -16.14%
09:01AM  Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial Benzinga
Jul-31-18 05:22PM  NewLink: 2Q Earnings Snapshot Associated Press
04:01PM  NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance GlobeNewswire
02:30PM  Newlink Genetics Corporation to Host Earnings Call ACCESSWIRE
Jul-13-18 07:40AM  Complimentary Technical Snapshots on OHR Pharma and Three More Biotech Stocks ACCESSWIRE
Jul-10-18 09:00AM  NewLink Genetics to Host Its Second Quarter 2018 Financial Results Conference Call on July 31, 2018 GlobeNewswire
Jul-02-18 08:01AM  NewLink Genetics Announces Positive Updated Phase 1 Data with Indoximod Plus Radio-Immunotherapy for Pediatric Patients with DIPG Presented at ISPNO 2018 Business Wire
Jun-30-18 05:32PM  The Week Ahead In Biotech: Delayed Clinical Trial Releases In Focus Benzinga
Jun-20-18 09:00AM  NewLink Genetics Announces Updated Data for Indoximod Plus Radio-Immunotherapy in DIPG to be Presented at ISPNO 2018 Meeting GlobeNewswire
Jun-12-18 08:05AM  Breakfast Technical Briefing on Omeros and Three Other Additional Biotech Stocks ACCESSWIRE
Jun-05-18 08:25AM  Detailed Research: Economic Perspectives on Central European Media Enterprises, Valeant Pharmaceuticals International, Nice, NCS Multistage, NewLink Genetics, and Colliers International Group What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jun-04-18 02:15PM  NewLink Genetics Announces Final Results from Two Phase 2 Studies of Indoximod Presented at ASCO 2018 Business Wire
May-30-18 09:00AM  NewLink Genetics to Participate in the Jefferies 2018 Global Healthcare Conference GlobeNewswire -5.48%
May-16-18 05:00PM  NewLink Genetics Announces Final Results from Phase 2 Studies of Indoximod in Advanced Melanoma and Metastatic Pancreatic Cancer to be Presented at ASCO 2018 GlobeNewswire
May-09-18 03:46AM  Edited Transcript of NLNK earnings conference call or presentation 3-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-03-18 05:46PM  NewLink: 1Q Earnings Snapshot Associated Press
04:01PM  NewLink Genetics Reports First Quarter 2018 Financial Results GlobeNewswire
May-01-18 09:00AM  NewLink Genetics Appoints Matthew L. Sherman, M.D. to Board of Directors GlobeNewswire +5.70%
Apr-30-18 09:00AM  NewLink Genetics to Participate in Upcoming Investor Conferences GlobeNewswire
Apr-25-18 03:55PM  NewLink Genetics Announces Presentation of Abstracts at ASCO 2018 Annual Meeting GlobeNewswire
Apr-20-18 09:00AM  NewLink Genetics to Host Its First Quarter 2018 Financial Results Conference Call on May 3, 2018 GlobeNewswire
Apr-17-18 09:00AM  NewLink Genetics Describes the Differentiated Mechanism of Action of Indoximod in AACR Poster Presentation Business Wire +10.79%
Apr-16-18 04:21PM  NewLink Shares Bite The Dust After Merck-Incyte Melanoma Failure Investor's Business Daily -7.72%
08:48AM  NewLink shares fall on late-stage trial changes MarketWatch
Apr-15-18 03:05PM  NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients with Diffuse Intrinsic Pontine Glioma (DIPG) Presented During AACR Plenary GlobeNewswire
Apr-10-18 08:15AM  New Research Coverage Highlights Golden Star Resources, Ryanair, Sasol, Access National, NewLink Genetics, and Canadian Pacific Railway Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Apr-09-18 05:24PM  NewLink Shares Plunge After Incyte & Merck's Study Fails Zacks -8.10%
03:51PM  Benzinga's Top Analyst Calls From April 9, 2018 Benzinga
02:24PM  NewLink Genetics' Potential Catalysts Not Enough To Justify A Bullish Stance, Baird Says In Downgrade Benzinga
10:29AM  Cantor Fitzgerald Double Downgrades NewLink Genetics After Incyte's Disappointing Trial Benzinga
09:48AM  Incyte's Epacadostat Fails in Melanoma Study, Shares Plunge Zacks
Apr-06-18 03:14PM  NewLink will review clinical programs after Merck, Incyte trial failure MarketWatch -42.62%
03:00PM  NewLink Genetics Announces Review of Clinical Programs GlobeNewswire
02:39PM  Benzinga's Top Analyst Calls From April 6, 2018 Benzinga
01:54PM  Why Incyte and NewLink Genetics Crashed Today Motley Fool
09:14AM  NewLink Genetics shares plummet 39% after Merck, Incyte trial failure MarketWatch
Apr-03-18 09:00AM  NewLink Genetics Announces Participation at The H.C. Wainwright Annual Global Life Sciences Conference GlobeNewswire
Mar-29-18 08:51AM  Options Traders Expect Huge Moves in NewLink Genetics (NLNK) Stock Zacks
Mar-21-18 09:00AM  NewLink Genetics Appoints Chad A. Johnson to Board of Directors GlobeNewswire
Mar-15-18 07:55AM  Factors of Influence in 2018, Key Indicators and Opportunity within NewLink Genetics, Chipmos Technologies, Helen of Troy, InterDigital, Summit Therapeutics, and Kornit Digital New Research Emphasizes Economic Growth GlobeNewswire -6.95%
Mar-14-18 05:00PM  NewLink Genetics Announces Presentation of Abstracts at AACR Annual Meeting GlobeNewswire
Mar-12-18 09:00AM  NewLink Genetics to Participate in Upcoming Investor Conferences GlobeNewswire
Mar-02-18 10:06AM  Edited Transcript of NLNK earnings conference call or presentation 1-Mar-18 9:30pm GMT Thomson Reuters StreetEvents +8.58%
Mar-01-18 04:57PM  NewLink reports 4Q loss Associated Press
04:01PM  NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs GlobeNewswire
12:45PM  Newlink Genetics Corporation to Host Earnings Call ACCESSWIRE
Feb-20-18 08:16PM  Zogenix Inc. (ZGNX) and Arena Pharmaceuticals, Inc. (ARNA) Helped This Healthcare-Focused Fund Earn Double-Digit Returns Insider Monkey
Feb-16-18 09:00AM  NewLink Genetics to Host Its Fourth Quarter and Year End 2017 Financial Results Conference Call on March 1, 2018 GlobeNewswire
Feb-06-18 09:00AM  NewLink Genetics to Participate in Upcoming Investor Conferences GlobeNewswire
Jan-16-18 07:54AM  What Do Analysts Think About NewLink Genetics Corporations (NASDAQ:NLNK) Earnings Trend? Simply Wall St.
Jan-08-18 02:29PM  Newman Ferrara LLP Announces Corporate Governance Investigation of NewLink Genetics Corporation Business Wire -6.06%
08:00AM  NewLink Genetics Outlines 2018 Business Priorities to Support Phase 3 Pivotal Trial of Indoximod Plus PD-1 Inhibitors GlobeNewswire
Dec-21-17 09:00AM  NewLink Genetics to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Nov-27-17 09:24AM  NewLink Genetics to Participate in Upcoming Investor Conference GlobeNewswire
Nov-20-17 04:25PM  NewLink Genetics Announces the Presentation of Indoximod Data in Phase 1 Study for Children GlobeNewswire
Nov-14-17 09:00AM  NewLink Genetics Appoints Eugene Kennedy, M.D. as Chief Medical Officer GlobeNewswire -6.07%
Nov-13-17 10:30AM  NewLink Genetics to Participate in November Investor Conferences GlobeNewswire
Nov-07-17 06:36AM  Edited Transcript of NLNK earnings conference call or presentation 2-Nov-17 12:30pm GMT Thomson Reuters StreetEvents
Nov-02-17 08:36AM  NewLink reports 3Q loss Associated Press -7.25%
08:00AM  NewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod Program GlobeNewswire
06:20AM  Newlink Genetics Corporation to Host Earnings Call ACCESSWIRE
Oct-30-17 09:32AM  NewLink Jumps on Orphan Drug Status for Melanoma Treatment -- Biotech Movers TheStreet.com
09:00AM  NewLink Genetics Announces FDA Orphan-Drug Designation for Indoximod GlobeNewswire
Oct-20-17 08:00AM  NewLink Genetics to Host Its Third Quarter 2017 Financial Results Conference Call on November 2, 2017 GlobeNewswire
Oct-16-17 09:57AM  ETFs with exposure to NewLink Genetics Corp. : October 16, 2017 Capital Cube
Oct-13-17 09:58AM  Bank Of America Sees NewLink Genetics As 'Undervalued' Benzinga
Oct-09-17 11:34AM  The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September Motley Fool
Oct-04-17 12:42PM  Here's Why NewLink Genetics Corp. Stock Is Surging Again Today Motley Fool +8.80%
08:36AM  Before You Invest In NewLink Genetics Corporation (NLNK), Consider This Factor Simply Wall St.
08:00AM  Today's Research Reports on Trending Tickers: Anthera Pharmaceuticals and NewLink Genetics ACCESSWIRE
Oct-03-17 08:54PM  NewLink Genetics Prices Public Offering of Common Stock GlobeNewswire +5.00%
06:15PM  Edited Transcript of NLNK earnings conference call or presentation 28-Jul-17 12:30pm GMT Thomson Reuters StreetEvents
04:07PM  NewLink Genetics Announces Proposed Public Offering of Common Stock Business Wire
Oct-02-17 10:59AM  ETFs with exposure to NewLink Genetics Corp. : October 2, 2017 Capital Cube
Sep-25-17 06:00AM  NewLink Genetics Announces Clinical Collaboration to Evaluate IO-Based Combination Therapies in Pancreatic Cancer GlobeNewswire -8.19%
06:00AM  NewLink Genetics Announces Clinical Collaboration to Evaluate IO-Based Combination Therapies in Pancreatic Cancer Business Wire
Sep-21-17 07:47AM  3 Small-Cap Biotech Stocks to Buy This Fall Motley Fool
Sep-19-17 06:12PM  ETFs with exposure to NewLink Genetics Corp. : September 19, 2017 Capital Cube
NewLink Genetics Corporation, a late clinical-stage immuno-oncology company, focuses on discovering and developing novel immunotherapeutic products for the treatment of patients with cancer. It is developing NLG2103, a combination of indoximod and standard of care checkpoint inhibitors, which is in Phase II clinical trial for treating patients with advanced melanoma; and Indigo301, a combination of indoximod with a checkpoint inhibitor that is in Phase III clinical trial for treating patients with advanced unresectable or metastatic melanoma, as well as combination of indoximod with other cancer therapeutics for patients with melanoma, pancreatic cancer, pediatric brain tumors, and acute myeloid leukemia. The company is also developing NLG802, a prodrug of indoximod, which has completed Phase I clinical trial; and NLG919, a clinical stage indoleamine-2, 3-dioxygenase pathway inhibitor. In addition, it is developing tergenpumatucel-L and dorgenmeltucel-L that are in Phase II clinical trials for treating patients with advanced lung cancer and melanoma; and CRLX101 and CRLX301, which are in early clinical development to treat patients with advanced solid malignancies. The company has strategic collaboration agreement with AstraZeneca to evaluate the combination of indoximod and durvalumab, an anti-PD-L1 monoclonal antibody for treating patients with metastatic pancreatic cancer; Genentech Inc. for the development and commercialization of NLG919, as well as a research collaboration for the discovery of next generation IDO/TDO inhibitors; and Merck Sharpe and Dohme Corp. to research, develop, and commercialize rVSV G-ZEBOV GP, an Ebola vaccine product candidate. NewLink Genetics Corporation was founded in 1999 and is headquartered in Ames, Iowa.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Talarico Ernest IIIDirectorJul 10Option Exercise2.1013,80628,99346,029Jul 12 04:21 PM
Talarico Ernest IIIDirectorJul 10Sale4.8213,80666,60032,223Jul 12 04:21 PM
Langren Carl W.Principal Accounting OfficerNov 21Option Exercise2.109,52319,99821,895Nov 22 06:41 PM
Langren Carl W.Principal Accounting OfficerNov 21Sale9.052,22920,17219,666Nov 22 06:41 PM